studyfinds15h
Alzheimer’s drug breakthrough or breakdown? Investigation exposes red flags in FDA approval of donanemab
A startling investigation has revealed a troubling story behind donanemab's approval -- one of questionable data, potential ...
McKnight's Long-Term Care News6h
Journalists question safety and effectiveness of new Alzheimer’s drug
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...
Investigation Discloses Safety, Efficacy Concerns About Eli Lilly's Donanemab
An investigation, published in the journal The BMJ, found that the newly U.S. Food & Drug Administration-approved donanemab is linked ...
Questions over safety and effectiveness of new Alzheimer's drug
The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is ...
News Medical on MSN1d
Concerns raised over safety and effectiveness of donanemab for Alzheimer’s treatment
The safety and effectiveness of donanemab - an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA) ...
Neuroscience News1d
Alzheimer’s Drug Faces Scrutiny Over Safety, Efficacy Concerns
The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according ...
BMJ1d
Donanemab: Conflicts of interest found in FDA committee that approved new Alzheimer’s drug
A new drug for Alzheimer’s disease is causing excitement despite excess deaths, missing safety data, questionable efficacy, and financial conflicts of interest among the “independent” advisory ...
Eli Lilly's Early Alzheimer's Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
Eli Lilly's Kisunla (donanemab) has been approved in Japan for early symptomatic Alzheimer's, including mild cognitive ...
Japan approves new drug 'donanemab' to treat Alzheimer's disease
Japan's health ministry has officially approved the domestic production and sale of a new drug for Alzheimer's disease.
Daily Express13h
Alzheimer's breakthrough as wonder drug approved - but might not be available in the UK
In the US, the FDA approved a new Alzheimer's treatment in July 2024 called donanemab. The treatment is for people with early symptomatic Alzheimer's disease, including mild cognitive impairment and ...
Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease
The Ministry of Health, Labour and Welfare Japan has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four weeks ...
The i on MSN1d
Alzheimer’s ‘wonder drug’ was approved by scientists funded by pharma firm
A “game-changing” new Alzheimer’s treatment was approved for use in the US by “independent” scientists who had received ...